Go to Contents Go to Navigation

Medifron DBT to raise 13 bln won via stock sale

All News 18:10 June 22, 2022

SEOUL, June 22 (Yonhap) -- Medifron DBT Co.on Wednesday announced that it will sell stocks to raise 13 billion won (US$10 million). The proceeds from the stock offering will be used primarily to finance its operations.

According to a regulatory filing, the company will issue some 8.66 million preferred shares at a price of 1,500 won per share. The stocks will be sold to the investors that the firm designated.

Issue Keywords
Most Liked
Most Saved
Most Viewed More
Send Feedback
How can we improve?
Thanks for your feedback!